Data from EMC - Curated by EPG Health - Last updated 04 August 2016


Pentostam should be used in accordance with international and local treatment guidelines. Consideration should be given to visceral leishmaniasis resistance patterns prior to administration.

Pentostam is indicated for the following diseases:

Visceral leishmaniasis (kala azar).

Cutaneous leishmaniasis.

South American mucocutaneous leishmaniasis.

Pentostam may also be of value in the treatment of leishmaniasis recidivans and diffuse cutaneous leishmaniasis in the New World.


- There is limited data available on the effectiveness of sodium stibogluconate to treat cutaneous and diffuse cutaneous leishmaniasis caused by Leishmania infantum and Leishmania aethiopica.


Full Prescribing information

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Inflammatory bowel disease assessment tools

Inflammatory bowel disease assessment tools

'New IBD assessment tools at a glance' - an educational symposium sponsored by Sandoz.

Fluid Management

Fluid Management

Are you up-to-date with the latest evidence of effective procedures for fluid management?

+ 2 more

Sleep Apnea

Sleep Apnea

Sleep apnea is a chronic condition characterised by recurrent interruptions in breathing throughout the sleep cycle. Learn about the two main types of sleep apnea and hear from experts as they present the latest research at the Sleep and Breathing conference (Marseille, 2019).

Load more

Related Content

More information

Category Value
Orphan designation No
Type POM
Marketing authorisation holder GlaxoSmithKline UK